BNN Share Price Performance
€2.25
-0.33 (-12.79%)
Price €2.25
Share Price€2.25
Is BRAIN Biotech (ETR:BNN) Weighed On By Its Debt Load?
Aug 26
BRAIN Biotech AG Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 5 Fair Values set on narratives written by author
BNN Community Narratives
There are no narratives available yet.
Recent BNN News & Updates
BRAIN Biotech AG Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Jan 14, 2026
- Earnings per share (EPS)
- -0.54
- Gross Margin
- 55.93%
- Net Profit Margin
- -21.81%
- Debt/Equity Ratio
- 0%
BRAIN Biotech AG Competitors
Snowflake Analysis
About BNN
- Founded
- 1993
- Employees
- 300
- CEO
- WebsiteView website
BRAIN Biotech AG provides bio-based products and solutions in Germany, the United States, France, the Netherlands, and the United Kingdom. It operates through three segments: BioProducts, BioScience, and BioIncubator. The company offers enzymes, biocatalysts, microorganisms, and other bioactive natural compounds to produce foodstuffs and animal feed, cosmetics, and medical products, as well as for industrial applications in chemical companies, waste and hazardous materials disposal, and energy and raw materials production. The company was formerly known as B.R.A.I.N. Biotechnology Research and Information Network AG and changed its name to BRAIN Biotech AG in April 2021. The company was founded in 1993 and is headquartered in Zwingenberg, Germany.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
German Market Performance
- 7 Days: 2.6%
- 3 Months: -0.3%
- 1 Year: 14.7%
- Year to Date: 13.3%
The market is up 2.6% in the last 7 days, led by the Industrials and all sectors gaining ground. The market is up 15% over the last 12 months. Looking forward, earnings are forecast to grow by 17% annually. Market details ›